TIAVE Trademark

Trademark Overview

On Monday, July 20, 2009, a trademark application was filed for TIAVE with the United States Patent and Trademark Office. The USPTO has given the TIAVE trademark a serial number of 77785083. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2013. This trademark is owned by Glaxo Group Limited. The TIAVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
tiave

General Information

Serial Number77785083
Word MarkTIAVE
Filing DateMonday, July 20, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 23, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 15, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 15, 2013ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 8, 2013EXTENSION 4 GRANTED
Monday, December 3, 2012EXTENSION 4 FILED
Monday, December 3, 2012TEAS EXTENSION RECEIVED
Wednesday, June 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 19, 2012EXTENSION 3 GRANTED
Monday, June 11, 2012EXTENSION 3 FILED
Monday, June 11, 2012TEAS EXTENSION RECEIVED
Tuesday, December 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2011EXTENSION 2 GRANTED
Wednesday, November 23, 2011EXTENSION 2 FILED
Wednesday, November 23, 2011TEAS EXTENSION RECEIVED
Tuesday, June 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 19, 2011EXTENSION 1 GRANTED
Thursday, June 9, 2011EXTENSION 1 FILED
Tuesday, June 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 9, 2011TEAS EXTENSION RECEIVED
Tuesday, December 14, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2010PUBLISHED FOR OPPOSITION
Monday, September 13, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 7, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 17, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 17, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 16, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, May 14, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 5, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, May 5, 2010INQUIRY TO SUSPENSION E-MAILED
Wednesday, May 5, 2010SUSPENSION INQUIRY WRITTEN
Wednesday, April 21, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, April 21, 2010ASSIGNED TO LIE
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 21, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 21, 2009LETTER OF SUSPENSION E-MAILED
Wednesday, October 21, 2009SUSPENSION LETTER WRITTEN
Wednesday, October 21, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, October 21, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 21, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, October 21, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, October 12, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 12, 2009NON-FINAL ACTION E-MAILED
Monday, October 12, 2009NON-FINAL ACTION WRITTEN
Wednesday, October 7, 2009ASSIGNED TO EXAMINER
Thursday, July 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 23, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

tiave pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic